SGHERZA N, Mestice A, Larocca AMV, Musto P. Antibody response to breakthrough SARS-CoV-2 infection in “booster” vaccinated patients with multiple myeloma according to B/T/NK lymphocyte absolute counts and anti-CD38 treatments. Mediterr J Hematol Infect Dis [Internet]. 2024 Feb. 29 [cited 2024 May 10];16(1):e2024022. Available from: https://www.mjhid.org/mjhid/article/view/5618